Myotonine (Bethanechol Chloride)

Bethanechol Chloride, the active ingredient in Myotonine, is a muscarinic receptor agonist presented as an oral formulation for systemic use. It stimulates smooth muscle contraction in the urinary bladder and gastrointestinal tract, making it useful in managing postoperative urinary retention, neurogenic bladder dysfunction, and postoperative ileus in adult patients.

GNH USA supplies Myotonine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable sourcing for bulk and finished‑product orders across multiple regions.

Bethanechol Chloride (Myotonine) stimulates muscarinic receptors in the urinary and gastrointestinal tracts, promoting smooth‑muscle contraction.

- Post‑operative urinary retention: facilitates bladder emptying by increasing detrusor muscle contractility. - Neurogenic bladder dysfunction: improves bladder voiding efficiency in patients with neurologic impairment. - Post‑operative ileus: enhances gastrointestinal motility to reduce bowel stasis after surgery.

Bethanechol Chloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Abdominal cramping: discomfort due to increased GI motility. - Diarrhea: loose stools from enhanced intestinal activity. - Sweating: excess perspiration related to cholinergic stimulation. - Flushing: transient skin redness. - Nausea: feeling of queasiness. - Urinary urgency: sudden need to void.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate requiring medical attention. - Severe hypotension: dangerous drop in blood pressure. - Bronchospasm: airway constriction that may cause breathing difficulty. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity.

When prescribing Bethanechol Chloride, clinicians should consider several safety measures to minimize risk.

- Assess cardiac function: avoid use in patients with known bradyarrhythmias or recent myocardial infarction. - Evaluate respiratory status: caution in individuals with asthma or chronic obstructive pulmonary disease. - Monitor fluid balance: dehydration may exacerbate hypotensive effects. - Review concomitant cholinergic drugs: combined use can amplify muscarinic effects. - Adjust for renal impairment: dose may need modification in severe renal dysfunction. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Bethanechol Chloride can interact with other medications that influence cholinergic pathways or cardiovascular function.

Major Interactions (Avoid): - Anticholinergic agents (e.g., atropine, scopolamine): may block therapeutic effect. - Beta‑blockers: additive bradycardia risk. - Calcium channel blockers: potential for enhanced hypotension.

Moderate Interactions (Monitor Closely): - Other muscarinic agonists (e.g., pilocarpine): may increase cholinergic side effects. - Diuretics: may worsen hypotensive response. - Opioids: possible additive constipation after discontinuation.